§ BIOTECHNOLOGY
USD · BiotechnologyMLTX
MOONLAKE IMMUNOTHERAPEUTICS
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
119 increased/new, 48 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BVF INC/IL | 16.0M | 9.5% | −19% |
| Deep Track Capital, LP | 6.4M | 2.0% | +39% |
| Cormorant Asset Management, LP | 4.5M | 4.2% | +3% |
| JANUS HENDERSON GROUP PLC | 3.5M | n/a | +65% |
| DE Shaw | 2.4M | 0.0% | −4% |
| Vivo Capital, LLC | 2.0M | n/a | +100% |
◇ AC INTELLIGENCE
Top institutional owners for MLTX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER72.3% · 103 holders
QUALITY / COMPOUNDER10.0% · 6 holders
DEALER / BANK5.5% · 17 holders
TACTICAL / MACRO5.3% · 4 holders
ACTIVIST3.3% · 1 holder
PASSIVE / INDEX1.7% · 4 holders
SYSTEMATIC / QUANT1.1% · 8 holders
INCOME / DEFENSIVE0.2% · 5 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for MLTX in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention MLTX yet.